Literature DB >> 6795232

Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits.

W M Scheld, O Zak, K Vosbeck, M A Sande.   

Abstract

Bacterial adhesion to the constituents of nonbacterial thrombotic endocarditis (NBTE) is important in the pathogenesis of endocarditis. Subinhibitory concentrations (subMIC) of some antibiotics decrease bacterial adhesion to epithelial cells in vitro. We utilized an in vitro assay system to study the effect of subMIC of various antibiotics on streptococcal adhesion to a fibrin-platelet matrix (simulating NBTE). The results were (a) bacterial adhesion of Streptococcus sanguis and Streptococcus faecalis to NBTE was significantly reduced by vancomycin, penicillin, tetracycline, chloramphenicol and streptomycin (P less than 0.01 vs. controls) but not rifampin or trimethoprimsulfametrole; (b) the effect was dose-dependent and increased with duration of exposure to antibiotic; (c) reduction in bacterial adhesion did not correlate with altered retention by hydrophobic-interaction chromatography. This reduction in adhesion correlated with a diminished capacity of subMIC exposed Streptococcus sanguis (1/4 vancomycin minimum inhibitory concentration (MIC) X 4 h) to produce endocarditis in vivo. After intravenous inoculation of 10(6) colony-forming units of preincubated organisms into rabbits with traumatized aortic valves, 6 of 22 developed endocarditis vs. 17 of 22 controls (P = 0.03). These results may be relevant to prophylaxis of endocarditis since exposure of bacteria to subMIC of various antibiotics may reduce bacterial adherence both, to mucosal surfaces, and to damaged cardiac valves.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795232      PMCID: PMC370937          DOI: 10.1172/jci110388

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  7 in total

1.  Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.

Authors:  D T Durack; R G Petersdorf
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

2.  The effect of subinhibitory concentrations of penicillin and rifampicin on bacterial cell surface hydrophobicity and on binding to pharyngeal epithelial cells.

Authors:  S K Tylewska; T Wadström; S Hjerten
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

3.  Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin.

Authors:  W M Scheld; J A Valone; M A Sande
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

4.  Differences in hydrophobic surface characteristics of porcine enteropathogenic Escherichia coli with or without K88 antigen as revealed by hydrophobic interaction chromatography.

Authors:  C J Smyth; P Jonsson; E Olsson; O Soderlind; J Rosengren; S Hjertén; T Wadström
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

5.  Effects of subminimal inhibitory concentrations of antibiotics on adhesiveness of Escherichia coli in vitro.

Authors:  K Vosbeck; H Handschin; E B Menge; O Zak
Journal:  Rev Infect Dis       Date:  1979 Sep-Oct

Review 6.  Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface.

Authors:  E H Beachey
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

7.  Influence of preformed antibody on experimental Streptococcus sanguis endocarditis.

Authors:  W M Scheld; J H Thomas; M A Sande
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

  7 in total
  20 in total

1.  Role of adherence in infective endocarditis.

Authors:  M A Kielhofner; R J Hamill
Journal:  Tex Heart Inst J       Date:  1989

Review 2.  Medical complications of intravenous drug use.

Authors:  M D Stein
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

3.  Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.

Authors:  G S Perdikaris; A Pefanis; H Giamarellou; A Nikolopoulos; E P Margaris; I Donta; A Tsitsika; P Karayiannakos
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

Review 4.  Bacterial adhesion: modulation by antibiotics with primary targets other than protein synthesis.

Authors:  D M Schifferli; E H Beachey
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

5.  Protein-mediated adhesion of the dissimilatory Fe(III)-reducing bacterium Shewanella alga BrY to hydrous ferric oxide.

Authors:  F Caccavo
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

6.  Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro.

Authors:  M R Yeaman; P M Sullam; P F Dazin; A S Bayer
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein.

Authors:  M R Yeaman; S M Puentes; D C Norman; A S Bayer
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Interaction of beta-lactam antibiotics with the bactericidal activity of leukocytes against Escherichia coli.

Authors:  A Dalhoff
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

9.  Role of granulocytes in the prevention and therapy of experimental Streptococcus sanguis endocarditis in rabbits.

Authors:  M J Meddens; J Thompson; H Mattie; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

10.  Effect of penicillin on the adherence of Streptococcus sanguis in vitro and in the rabbit model of endocarditis.

Authors:  F D Lowy; D S Chang; E G Neuhaus; D S Horne; A Tomasz; N H Steigbigel
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.